These profiles include unique gene expression patterns associated with NPM1 mutations and also the expression levels of three genes (annexin A3, ANXA3; protein S100-A9, S100A9, and Wilms tumor 1, WT1) that can differentiate between AML FAB subtypes M1 from M2 [12,13]. Here, ANXA3 is linked to acute myeloid leukemia.